ZELUVALIMAB

20C1.009 AMG-404 AMG404 AMG 404 [WHO-DD] ANTI-PD-1 MONOCLONAL ANTIBODY AMG 404 IMMUNOGLOBULIN G1 (295-CYSTEINE,300-GLYCINE,305-CYSTEINE), ANTI-(HUMAN PROGRAMMED CELL DEATH 1) (HUMAN MONOCLONAL 20C1.009 MAB .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 20C1.009 MAB .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (PROTEIN PD-1; HPD-1; ANTIGEN=CD279)), HUMAN MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-450)(VH (HOMO SAPIENS IGHV3-23*03 (93%)-(IGHD)-IGHJ1*01 (91%)) (8.8.13) (1-120)-IGHG1*03 (CH1(R97>K(217)), CH2(R62>C(295), N67>G(300), V72>C(305))) (121-450)) (223-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-12*01 (97%)-IGKJ4*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN CHO CELLS, NON-GLYCOSYLATED RECOMBINANT HUMAN IgG1 KAPPA ANTI PD1 MONOCLONAL ANTIBODY AMG 404 ZELUVALIMAB (IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY) zeluvalimab [INN] ZELUVALIMAB [USAN]